GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (STU:THR) » Definitions » Gross Margin %

ThermoGenesis Holdings (STU:THR) Gross Margin % : -1.59% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is ThermoGenesis Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. ThermoGenesis Holdings's Gross Profit for the three months ended in Dec. 2023 was €-0.04 Mil. ThermoGenesis Holdings's Revenue for the three months ended in Dec. 2023 was €2.21 Mil. Therefore, ThermoGenesis Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was -1.59%.

Warning Sign:

ThermoGenesis Holdings Inc gross margin has been in long-term decline. The average rate of decline per year is -2.9%.


The historical rank and industry rank for ThermoGenesis Holdings's Gross Margin % or its related term are showing as below:

STU:THR' s Gross Margin % Range Over the Past 10 Years
Min: 12.92   Med: 27.73   Max: 43.66
Current: 20.45


During the past 13 years, the highest Gross Margin % of ThermoGenesis Holdings was 43.66%. The lowest was 12.92%. And the median was 27.73%.

STU:THR's Gross Margin % is ranked worse than
87.81% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.295 vs STU:THR: 20.45

ThermoGenesis Holdings had a gross margin of -1.59% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for ThermoGenesis Holdings was -2.90% per year.


ThermoGenesis Holdings Gross Margin % Historical Data

The historical data trend for ThermoGenesis Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings Gross Margin % Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.66 12.92 37.58 25.85 20.45

ThermoGenesis Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.73 42.96 20.64 18.00 -1.59

Competitive Comparison of ThermoGenesis Holdings's Gross Margin %

For the Medical Devices subindustry, ThermoGenesis Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's Gross Margin % falls into.



ThermoGenesis Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

ThermoGenesis Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1.8 / 8.661
=(Revenue - Cost of Goods Sold) / Revenue
=(8.661 - 6.89) / 8.661
=20.45 %

ThermoGenesis Holdings's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-0 / 2.206
=(Revenue - Cost of Goods Sold) / Revenue
=(2.206 - 2.241) / 2.206
=-1.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


ThermoGenesis Holdings  (STU:THR) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ThermoGenesis Holdings had a gross margin of -1.59% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


ThermoGenesis Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (STU:THR) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.

ThermoGenesis Holdings (STU:THR) Headlines